BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

Insilico Medicine Launches First Human Study for ISM5411, Oral PHD Inhibitor for IBD

ISM5411 is an oral, PHD-specific inhibitor that facilitates the treatment of IBD by inducing the expression of gut barrier protective genes. ISM5411 is ...

December 05, 2023 | News

Bahrain Secures Latest Human Genome Sequencing Machine in the Middle East

The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the Nati...

November 30, 2023 | News

XtalPi and EDDC Collaborate on Biomedical Innovation with Robotics and Language Models

Building upon an ongoing collaboration that was initiated in December 2022 to utilize artificial intelligence (AI) and automation to develop targ...

November 22, 2023 | News

Viva Biotech Secures Approximately US$ 210 Million Funding

Before, the publicly listed company at the group level had already secured approximately US$ 60 million in convertible bond financing, which will...

November 21, 2023 | News

Metabolon and Trajan Partner for Advanced Metabolomics Microsampling

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical...

November 21, 2023 | News

CU Medicine Innovates MOZAICTM Microbiome Tech for Fecal Microbiota Transplants

Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up...

November 17, 2023 | News

SCG Cell Therapy's SCG101 Shows Promising Results in First-in-Human Trial for Advanced HBV-related Hepatocellular Carcinoma at AASLD Liver Meeting 2023

Results from a first-in-human clinical trial showed that SCG101 demonstrated promising antiviral and antitumor activities in patients with advanced HBV-rel...

November 14, 2023 | News

Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA

The R&D Center will focus on advancing molecular diagnostic technologies and novel therapeutic platforms. Situated at the heart of the burgeoning biote...

November 13, 2023 | News

Cromatic closes $5.3 million in oversubscribed seed round to modernize life science R&D outsourcing

Cromatic, a full-stack digital platform for outsourced life sciences research, announced it has closed $5.3 million in funding. LifeX Ventures ...

November 10, 2023 | News

PharmAbcine Advances PMC-403 Clinical Trial in South Korea for Macular Degeneration

Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...

November 10, 2023 | News

DiscGenics Collaborates with U.S. Department of Veterans Affairs on Tissue-Engineered Discs

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate p...

November 10, 2023 | News

Genome Insight Secures $23 Million in Series B-2 Funding Round

This investment will support Genome Insight’s pursuit of bringing whole-genome based precision diagnostics to routine clinical care. Earlier this yea...

November 03, 2023 | News

AusBiotech 2023 kicks off in Brisbane with 1,200 delegates representing global life science ecosystem

Held in Brisbane from 1-3 November, Australia’s biggest week in biotech features its flagship event, AusBiotech 2023, which today launches with more ...

November 01, 2023 | News

AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech

Australia’s biggest week is officially underway, with AusBioInvest 2023 kicking off today in Melbourne to an audience of investors and life sci...

October 30, 2023 | News

Stay Connected